-
Mashup Score: 5People who mostly sit at work have a 16% higher risk of mortality, study says | CNN - 3 month(s) ago
Just a little light physical activity during work can improve health. Here’s how to incorporate “exercise snacks” and improve your health, even if you’re desk-bound.
Source: us.cnn.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 13
Previously published short‐term results (week 16) of this trial showed a significant improvement in clinical, radiologic and biochemical outcomes in Crohn’s disease patients with therapy‐refractory perianal fistulas after treatment with …
Source: www.ncbi.nlm.nih.govCategories: Gastroenterology, Latest HeadlinesTweet-
#hyperbaric oxygen therapy #HBOT can add value as in patients with perianal #CD Insurance coverage👎, I have a pt who purchased for his 🏠 Recent data on use for perianal #CD is promising https://t.co/I3kUZSEqGj In meta-analysis pooled repsonse 87%! https://t.co/qx6dCYmRTV https://t.co/kfsTmA7p99
-
-
Mashup Score: 2Ileocecal resection may have role as ‘primary treatment’ in recently diagnosed Crohn’s - 12 month(s) ago
CHICAGO — Patients who underwent ileocecal resection for Crohn’s disease had a 33% lower risk for hospitalization, repeat surgery, systemic corticosteroid exposure and perianal CD, according to a presenter at Digestive Disease Week. “The LIR!C trial has demonstrated comparable quality of life with ileocecal resection compared to infliximab as a first-line treatment for limited,
Source: www.healio.comCategories: Gastroenterology, Latest HeadlinesTweet-
#ICYMI from @DDWMeeting: "Additional #research is needed to understand features associated with lack of post-operative #CD progression," @ManasiAgrawalMD told @GoHealio #GI. #DDW23 https://t.co/ciAzHTUc4b
-
-
Mashup Score: 1High-dimensional profiling reveals Tc17 cell enrichment in active Crohn’s disease and identifies a potentially targetable signature - 2 year(s) ago
The immune-pathology in Crohn’s disease is linked to dysregulated CD4+ T cell responses biased towards pathogenic TH17 cells. However, the role of CD8+ T cells able to produce IL-17 (Tc17 cells) remains unclear. Here we characterize …
Source: PubMed Central (PMC)Categories: Infectious Disease, Latest HeadlinesTweet-
Truly an honor to work on this incredible translational #CD #IBD work identifying Tc17 cells in intestinal tissue & blood linked to dz activity & flare-free survival. Collaboration like this helps ID therapeutic targets in & understand causes of #IBD. https://t.co/5LiOvmRQGJ
-
-
Mashup Score: 0CD sales grow for first time since 2004 - 2 year(s) ago
2021 CD sales were up more than $100 million from 2020.
Source: AxiosCategories: Healthcare Professionals, Latest HeadlinesTweet-
#CD sales grow for first time since 2004 https://t.co/GwnxIxE7EC // cc @cdbaby
-
-
Mashup Score: 5Crohn's & Colitis Foundation - 2 year(s) ago
Crohn’s & Colitis Foundation
Categories: Gastroenterology, Latest HeadlinesTweet-
📢 Calling all #GI providers who care for #IBD pts @CrohnsColitisFn #Florida chapter is putting on a multidisciplinary session Management of Intestinal Strictures in #CD with @IBD_Afzali @LucaStocchiMD #udaynavaneethan #amitmerchea Register for FREE https://t.co/I85LUiOgN9 https://t.co/NdjShmynEx
-
-
Mashup Score: 3CD exclusion diet induces, maintains remission in Crohn’s - 2 year(s) ago
The Crohn’s disease exclusion diet with or without enteral nutrition induced and maintained remission in adult patients with mild to moderate CD and may lead to full endoscopic remission. “The current goal of medical therapy is to reduce inflammation and induce mucosal healing, which can be achieved by modifying immune pathways; however, many of the drugs used to manage Crohn’s
Source: www.healio.comCategories: Gastroenterology, Latest HeadlinesTweet-
#ICYMI: #CD exclusion diet induces, maintains remission in #Crohns #GITwitter @LancetGastroHep https://t.co/YmgVEkAic8
-
-
Mashup Score: 10Contemporary Risk of Surgery in Patients With Ulcerative Colitis and Crohn’s Disease: A Meta-Analysis of Population-Based Cohorts - 3 year(s) ago
We conducted a systematic review with meta-analysis to estimate rates and trends of colectomy in patients with ulcerative colitis (UC), and of primary and re-resection in patients with Crohn’s disease (CD), focusing on contemporary risks.
Categories: Gastroenterology, Latest HeadlinesTweet-
Patient-level risks of surgery have decreased significantly over time, with a 5-year cumulative risk of surgery of 7.0% in UC and 18.0% in #CD in contemporary cohorts. This decrease may be related to early detection and/or better treatment https://t.co/AEtR7mHpKr https://t.co/IfqvLtoUeZ
-
-
Mashup Score: 3High-Dose Vitamin D Does Not Prevent Postoperative Recurrence of Crohn’s Disease in a Randomized Placebo-Controlled Trial - 3 year(s) ago
Vitamin D deficiency is common in Crohn’s disease (CD). High-dose vitamin D had anti-inflammatory effects in preclinical studies and trials of patients with CD. We performed a randomized trial to determine whether high-dose vitamin D prevents postoperative recurrence of CD after ileocolonic resection.
Categories: Gastroenterology, Latest HeadlinesTweet-
High-dose vitamin D, compared with placebo, did not reduce the incidence of postoperative endoscopic or clinical recurrence of #CD in patients who underwent ileocolonic resection with ileocolonic anastomosis https://t.co/TfQlsEE31a https://t.co/lXn3husmrN
-
-
Mashup Score: 0VIDEO: Stelara, Humira safely, effectively treat CD - 3 year(s) ago
Stelara and Humira demonstrated rapid onset of action and effectiveness in the treatment of patients with moderate to severe Crohn’s disease, Bruce Sands, MD, Icahn School of Medicine, told Healio Gastroenterology. In a multicenter, blinded, active-controlled study, researchers randomly assigned 386 biologic-naive patients 1:1 to receive either Stelara (ustekinumab, Janssen) or Humira
Source: www.healio.comCategories: Gastroenterology, Latest HeadlinesTweet-
#ICYMI: “[T]his may inform our use of these biologic agents in first-line therapy for patients with #CD and hopefully will contribute greatly to the field," Bruce Sands, MD, @IcahnMountSinai @DDWMeeting #DDW2021 #GITwitter https://t.co/Ei4OdseHoS
-
Tired of sitting at a desk all day long? Turns out it’s not good for your health, either. People who predominantly sit at work have a 16% higher risk of mortality from all causes & a 34% higher risk of mortality from #CD. Learn more @JAMANetworkOpen. https://t.co/ZjhPhLb3mC